MSA
SCMP

Mason Street Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Mason Street Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,550
Closed -$118K – 1529
2017
Q4 		$118K Buy
6,550
+183
+3% +$2.25K ﹤0.01% 1441
2017
Q3 		$75K Buy
6,367
+179
+3% +$2.01K ﹤0.01% 1483
2017
Q2 		$65K Buy
6,188
+400
+7% +$4.08K ﹤0.01% 1481
2017
Q1 		$64K Buy
+5,788
New +$67.2K ﹤0.01% 1481

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Mason Street Advisors's SCMP Position: Q1 2018 in Review

Mason Street Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 6,550 shares — an estimated $118K sold.

Mason Street Advisors first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $118K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Mason Street Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Mason Street Advisors sold 6,550 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $118K.
  • Mason Street Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Mason Street Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $118K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Mason Street Advisors's 13F filing for Q1 2018, filed 14 May 2018.